- Approval Id
- 2da565a5c2f42fbd
- Drug Name
- TECHNESCAN HDP FOR INJECTION 3 MG/VIAL
- Product Name
- TECHNESCAN HDP FOR INJECTION 3 MG/VIAL
- Approval Number
- SIN12151P
- Approval Date
- 2002-12-23
- Registrant
- QT INSTRUMENTS (S) PTE LTD
- Licence Holder
- QT INSTRUMENTS (S) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- INJECTION, POWDER, FOR SOLUTION
- Dosage
- <p><strong>Posology and method of administration</strong><br>
The average activity administered by single intravenous injection is 500 MBq (300 – 700 MBq) in a 50 to 70 kg adult. Other activities may be justifiable. There is no special dosage regimen for the elderly patient. The dose to be administered to a child should be a fraction of the adult dose calculated from the body weight according to the following table.</p>
<img src="/TGIF/TechnescanHDPForInjection-Table1_201223.png" alt="Technescan HDP For Injection Dosage Table 1" /><br><br>
<p>In very young children (up to 1 year) a minimum dose of 40 MBq is necessary in order to obtain images of sufficient quality.</p>
<p>Images obtained shortly after injection (e.g. in the so-called "3-phase bone scan" procedure) will only partly reflect metabolic activity. Late phase static scintigraphy should be performed not earlier than 2 hours after injection. The patient should void before scanning.</p>
- Route Of Administration
- INTRAVENOUS
- Indication Info
- <p><strong>Therapeutic indications</strong><br>
After reconstitution with Sodium Pertechnetate (<sup>99m</sup>Tc) Injection (Fission or Non-Fission) the agent may be used for bone scintigraphy, where it delineates areas of altered osteogenesis.</p>
- Contraindications
- <p><strong>Contra-indications</strong><br>
There are no specific contra-indications.</p>
- Atc Code
- V09BA01
- Atc Item Name
- technetium (99mTc) oxidronic acid
- Pharma Manufacturer Name
- QT INSTRUMENTS (S) PTE LTD
- Company Detail Path
- /organization/qt-instruments-s-pte-ltd
